Last Update Time:
05-Feb-2025 16:00:00
ISIN:
INE112L01020
Sector:
Healthcare
Symbol:
METROPOLIS
Metropolis Healthcare Limited
₹1,806.00
₹68.10
(3.92%)
▲
Prev. Close
₹1,737.90
Open
₹1,755.00
Close
₹1,805.00
Range
₹1,715.70 - ₹1,896.30
High
₹1,833.90
Low
₹1,755.00
Ind. Close
₹0.00
VWAP
₹1,801.67
The current stock price of Metropolis Healthcare Limited is ₹1,806.00, with a target price range between ₹1,715.70 and ₹1,896.30. The stock has experienced a price change of ₹68.10 (3.92%), reflecting recent market volatility.
Today's opening price was ₹1,755.00, while the previous close stood at ₹1,737.90. The intraday high reached ₹1,833.90, and the low touched ₹1,755.00. The volume-weighted average price (VWAP) is currently ₹1,801.67, indicating the stock's average traded price.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Metropolis Healthcare Limited Price Chart
Metropolis Healthcare Limited Pre Open Market Overview: 05-Feb-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 1755
- Previous Close Price: 1737.9
- Change: 17.10%
- Total Traded Volume: 8,447
- Total Buy Quantity: 37,179
- Total Sell Quantity: 1,594
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 1,741.00 | 5.00 | 0.00 |
| 1,744.00 | 1.00 | 0.00 |
| 1,745.90 | 2.00 | 0.00 |
| 1,750.00 | 7.00 | 0.00 |
| 1,755.00 | 9,188.00 | 0.00 |
| 1,758.00 | 0.00 | 50.00 |
| 1,759.95 | 0.00 | 1.00 |
| 1,760.45 | 0.00 | 10.00 |
| 1,760.65 | 0.00 | 19.00 |
| 1,760.75 | 0.00 | 3.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 0
Total Sell Quantity: 0
Shareholding Patterns (in %) of Metropolis Healthcare Limited
| Category | 31-Dec-2023 | 31-Mar-2024 | 30-Jun-2024 | 30-Sep-2024 | 31-Dec-2024 |
|---|---|---|---|---|---|
| Promoter & Promoter Group | 49.74 | 49.67 | 49.62 | 49.43 | 49.40 |
| Public | 50.26 | 50.33 | 50.38 | 50.57 | 50.60 |
| Shares held by Employee Trusts | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Key Trade Statistics of Metropolis Healthcare Limited
The trade information for Metropolis Healthcare Limited includes a total traded volume of 6.09 lakh shares, and a traded value of ₹109.79 crore.
The market cap is ₹9,258.88 crore, with a free float market cap of ₹4,680.41 crore. The deliverable quantity is 213,219.00 shares, reflecting 34.99% of total trades.
Key risk indicators include security VaR at 12.1% and an applicable margin rate of 15.6%.
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 6.09 |
| Traded Value (₹ Cr.) | 109.79 |
| Total Market Cap (₹ Cr.) | 9,258.88 |
| Free Float Market Cap (₹ Cr.) | 4,680.41 |
| Impact cost | 0.05 |
| Quantity Traded | 609,369.00 |
| Deliverable Quantity | 213,219.00 |
| % of Quantity to Traded | 34.99 |
| Security VaR | 12.1 |
| Index VaR | N/A |
| VaR Margin | 12.1 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 15.6 |
| Face Value | 2 |
Key Price Statistics of Metropolis Healthcare Limited
The 52-week high for Metropolis Healthcare Limited was ₹2,318.30, recorded on 10-Oct-2024. On the other hand, the 52-week low stands at ₹1,551.05, with the lowest value recorded on 20-Mar-2024.
The upper band for trading is ₹N/A, and the lower band is ₹N/A. The price band is No Band%.
The stock's daily volatility stands at 1.90, while the annualized volatility is 36.30. The tick size for trading is ₹N/A.
| Price Information | Details |
|---|---|
| 52 Week High (10-Oct-2024) | 2,318.30 |
| 52 Week Low (20-Mar-2024) | 1,551.05 |
| Upper Band | 1,911.65 |
| Lower Band | 1,564.15 |
| Price Band (%) | No Band |
| Daily Volatility | 1.90 |
| Annualised Volatility | 36.30 |
| Tick Size | 0.05 |
Key Securities Statistics of Metropolis Healthcare Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 15-Apr-2019 |
| Adjusted P/E | 58.31 |
| Symbol P/E | 58.31 |
| Index | NIFTY 500 |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Basic Industry | Healthcare Service Provider |
Security Status of Metropolis Healthcare Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Metropolis Healthcare Limited
| Subject | Date |
|---|---|
| Analysts/Institutional Investor Meet/Con. Call Updates | 05-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 05-Feb-2025 |
| Copy of Newspaper Publication | 05-Feb-2025 |
| Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | 04-Feb-2025 |
| Investor Presentation | 04-Feb-2025 |
| Press Release | 04-Feb-2025 |
| Integrated Filing- Financial | 04-Feb-2025 |
| Outcome of Board Meeting | 04-Feb-2025 |
Corporate Actions of Metropolis Healthcare Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 2 | Interim Dividend - Rs 4 Per Share | 17-Nov-2023 |
| 2 | Annual General Meeting | 10-Aug-2023 |
| 2 | Interim Dividend - Rs 8 Per Share | 23-Feb-2023 |
| 2 | Annual General Meeting | 08-Aug-2022 |
| 2 | Interim Dividend - Rs. 8 Per Share | 21-Feb-2022 |
| 2 | Interim Dividend - Rs 8 Per Share | 17-Feb-2021 |
| 2 | Interim Dividend - Rs 8 Per Share | 13-Feb-2020 |
Board Meetings of Metropolis Healthcare Limited
Financial Results of Metropolis Healthcare Limited
| Qtr Ended | Tot. Income | Net P/L | EPS | Notes |
|---|---|---|---|---|
| 31 Dec 2024 | 29,991 | 2,740 | 5.35 | |
| 30 Sep 2024 | 32,516 | 4,226 | 8.24 | |
| 30 Jun 2024 | 28,896 | 3,128 | 6.11 | |
| 31 Mar 2024 | 29,429 | 3,178 | 6.21 | |
| 31 Dec 2023 | 27,460 | 2,670 | 5.21 |
Company Directory of Metropolis Healthcare Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| N/A | Head Office/ Corporate Office | NH-8, SCO NO. 30, SECTOR 15, PART II | GURGAON |
| N/A | Registered Office | 4th Floor, East Wing, Plot-254 B, Nirlon House Dr. Annie Besant Road Worli | MUMBAI |
| N/A | Transfer Agent | C-101, 1st Floor, 247 Park, L.B.S. Marg, Vikhroli (West) Mumbai | MUMBAI |
Insider Trading of Metropolis Healthcare Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Sushil Kanubhai Shah | 36687397 | Sell |
| 7(2) | Sushil Kanubhai Shah | 15752500 | Sell |
| 7(2) | Sushil Kanubhai Shah | 82370764 | Sell |
| 7(2) | Sushil Kanubhai Shah | 53306973 | Sell |
| 7(2) | Sushil Kanubhai Shah | 30080622 | Sell |
| 7(2) | Sushil Kanubhai Shah | 20450000 | Sell |
| 7(2) | Sushil Kanubhai Shah | 61854944 | Sell |
| 7(2) | SUSHIL SHAH | 0 | Sell |
| 7(2) | Sushil Shah Family Trust | 0 | Buy |
| 7(2) | Dr. Duru Sushil Shah | 0 | Sell |
| 7(2) | Duru Shah Family Trust | 0 | Buy |
| 7(2) | Dr. Duru Sushil Shah | 0 | Sell |
| 7(2) | Duru Shah Family Trust | 0 | Buy |
| 7(2) | SUSHIL SHAH | 843205 | Buy |
| 7(2) | SUSHIL SHAH | 99828456 | Buy |
| 7(2) | SUSHIL SHAH | 197196361 | Buy |
| 7(2) | SUSHIL SHAH | 194041 | Buy |
| 7(2) | Nayan Jadavji Gala | 820323 | Sell |
| 7(2) | Dr. Duru Sushil Shah | 1331112245 | Sell |
| 7(2) | Dr. Nilesh Shah | 7216800 | Sell |
Annual Reports of Metropolis Healthcare Limited
Investor Complaints of Metropolis Healthcare Limited
| Date | Pending | Received | Disposed | Unresolved |
|---|---|---|---|---|
| 31-Dec-2024 | 0 | 0 | 0 | 0 |
| 30-Sep-2024 | 0 | 0 | 0 | 0 |
| 30-Jun-2024 | 0 | 1 | 1 | 0 |
| 31-Mar-2024 | 0 | 0 | 0 | 0 |
| 31-Dec-2023 | 0 | 0 | 0 | 0 |
| 30-Sep-2023 | 0 | 1 | 1 | 0 |
| 30-Jun-2023 | 0 | 0 | 0 | 0 |
| 31-Mar-2023 | 0 | 2 | 2 | 0 |
| 31-Dec-2022 | 0 | 0 | 0 | 0 |
| 30-Sep-2022 | 0 | 0 | 0 | 0 |
| 30-Jun-2022 | 0 | 0 | 0 | 0 |
| 31-Mar-2022 | 0 | 0 | 0 | 0 |
| 31-Dec-2021 | 0 | 0 | 0 | 0 |
| 30-Sep-2021 | 0 | 0 | 0 | 0 |
| 30-Jun-2021 | 1 | 0 | 1 | 0 |
| 31-Mar-2021 | 0 | 1 | 0 | 1 |
| 31-Dec-2020 | 0 | 0 | 0 | 0 |
| 30-Sep-2020 | 0 | 0 | 0 | 0 |
| 30-Jun-2020 | 0 | 0 | 0 | 0 |
| 31-Mar-2020 | 0 | 0 | 0 | 0 |
| 31-Dec-2019 | 0 | 1 | 1 | 0 |
| 30-Sep-2019 | 0 | 0 | 0 | 0 |
| 30-Jun-2019 | 0 | 0 | 0 | 0 |
Event Calendar of Metropolis Healthcare Limited
| Purpose | Details |
|---|---|
| Financial Results | To consider and approve the financial results and final dividend, if any for the period ended March 31, 2019 |
| Financial Results | To consider and approve the financial results for the quarter ended June 30, 2019 |
| Financial Results | To consider and approve the Unaudited Standalone and Consolidated Financial Results for the period ended September 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
| Financial Results/Dividend | The Company had informed the Exchange regarding a Board Meeting scheduled to be held on February 06, 2020 To consider and approve the financial results for the period ended December 31, 2019. The Company has now informed the Exchange that the aforesaid also consider the declaration of interim dividend, if any, for the financial year 2019-20.( Purpose Revised) |
| Financial Results/Other business matters | This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, May 29, 2020 to inter-alia consider and approve the Audited Standalone and Consolidated Financial statements of the Company for the quarter and financial year ended March 31, 2020 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2020 and other business matters |
| Other business matters | Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Sunday January 17, 2021. |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended December 31, 2020, dividend and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2021 and other business matters |
| Financial Results/Fund Raising/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2021, Fund Raising and other business matters |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2021 and interim dividend, if any |
| Financial results | Metropolis Healthcare Limited has informed the Exchange about Board Meeting to be held on 24-May-2022 to consider financial statements for the period ended March 2022 |
| Other business matters | Metropolis Healthcare Limited has informed the Exchange about Board Meeting to be held on July 18, 2022, to consider and approve revised Audited Standalone Financial results for the quarter and year ended March 31, 2022, after taking on record the amalgamation of the 8 (Eight) wholly- owned subsidiary Companies with the Company. |
| Other business matters | Metropolis Healthcare Limited has informed the Exchange about Board Meeting to be held on July 18, 2022, to consider and approve revised Audited Standalone Financial results for the quarter and year ended March 31, 2022, after taking on record the amalgamation of the 8 (Eight) wholly- owned subsidiary Companies with the Company. |
| Financial results | Metropolis Healthcare Limited has informed the Exchange about Board Meeting to be held on 10-Aug-2022 to consider unaudited financial results for the quarter ended June 2022 |
| Financial results | Metropolis Healthcare Limited has informed the Exchange that Meeting of the Board of Directors of the Company is scheduled on Tuesday, November 08, 2022, to inter alia, consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022. |
| Financial Results/Dividend | Intimation of Notice of Board Meeting scheduled to be held on Friday, February 10, 2023 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2023 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2023 and Interim dividend for the financial year 2023-24 |
| Financial Results | To consider and approve the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended December 31, 2023. |
| Financial Results | To consider and approve the Audited Standalone & Consolidated Financial Results for the period ended March 31, 2024 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Fund Raising | To consider issuance of equity shares of the Company on a preferential basis |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Metropolis Healthcare Limited
Voting Results of Metropolis Healthcare Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 21-AUG-2024 | AGM | Adoption of Audited Financial Statements of the Company (including consolidated financial statements) for the financial year ended March 31, 2024, together with the Reports of the Board of Directors and Auditors thereon |
| 21-AUG-2024 | AGM | Approval of extension of the Metropolis-Restrictive Stock Unit Plan, 2020 to the eligible employees of the Subsidiary(ies) and/or Associate Company(ies), if any, of the Company. |
| 21-AUG-2024 | AGM | Approval of the revision in the pool size of Restrictive Stock Units (RSUs) and other terms of Metropolis ￢ﾀﾓRestrictive Stock Unit Plan ￢ﾀﾓ 2020. |
| 21-AUG-2024 | AGM | Approval of the appointment of Dr. Aparna Rajadhyaksha as Non-Executive Director of the Company. |
| 21-AUG-2024 | AGM | Approval of the change in designation of Ms. Ameera Shah from Managing Director to Whole-Time Director in the capacity of Chairperson of the Company and revision in terms of remuneration. |
| 21-AUG-2024 | AGM | Approval of the remuneration payable to Dr. Sushil Shah as Non-Executive Non-Independent Director of the Company. |
| 21-AUG-2024 | AGM | Approval of change in designation of Dr. Sushil Shah from Whole-Time Director to Non-Executive Non-Independent Director of the Company. |
| 21-AUG-2024 | AGM | Ratification of the remuneration payable to M/s. Joshi Apte & Associates, Cost Auditors of the Company for the financial year 2024-25 |
| 21-AUG-2024 | AGM | Appointment of a Director in place of Dr. Sushil Shah (DIN: 00179918), who retires by rotation and being eligible, offers himself for the re-appointment. |
| 21-AUG-2024 | AGM | Confirmation of Interim Dividend of INR 4/- (Indian Rupees Four Only) per equity share, declared by the Board as the final dividend for the financial year 2023-24. |
| 27-OCT-2023 | Postal Ballot | Appointment of Mr. Subramanian Ranganathan (DIN: 00125493) as a Non-Executive Independent Director of the Company |
| 17-AUG-2023 | AGM | Adoption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2023 together with the Reports of the Board of Directors and the Auditors thereon |
| 17-AUG-2023 | AGM | Re-appointment of Mr. Vivek Gambhir, (DIN: 06527810) as an Independent Director of the Company for a second term of five consecutive years |
| 17-AUG-2023 | AGM | Re-appointment of Mr. Sanjay Bhatnagar, (DIN: 00867848) as an Independent Director of the Company for a second term of five consecutive years |
| 17-AUG-2023 | AGM | Ratify the remuneration payable to M/s. Joshi Apte & Associates, Cost Auditors of the Company for the Financial Year 2023-24 |
| 17-AUG-2023 | AGM | Appointment of Mr. Hemant Sachdev (DIN: 01635195) as a Director of the Company, who retires by rotation, and being eligible offered herself for re-appointment |
| 17-AUG-2023 | AGM | Confirmation of payment of Interim Dividend of Rs. 8/- (Rupees Eight Only) per equity share for the financial year ended March 31, 2023 |
| 17-AUG-2022 | AGM | Adoption of Audited Standalone Financial Statements for the year ended March 31, 2022 together with the Reports of the Board of Directors and the Auditors thereon and the Audited Consolidated Financial Statements for the year ended March 31, 2022 and the reports of auditors thereon |
| 17-AUG-2022 | AGM | Re-appointment of Ms. Ameera Sushil Shah (DIN:00208095) as a Director of the Company, who retires by rotation and, being eligible, offers herself for re-appointment |
| 17-AUG-2022 | AGM | Confirmation of payment of Interim Dividend of 8/- (Rupees Eight Only) per equity share for the financial year ended March 31, 2022 |